Final Agenda

Subject to change

7:30 a.m. Registration Opens
8:00 a.m. Pre-Event Media Session with Rep. Cooper and Dr. Thomas Graf
8:30 a.m. Welcome: ASE Past President and Value Summit Chair, Benjamin F. Byrd III, MD, FASE
8:40 a.m. Value-Based Healthcare in the U.S. – A Congressional Perspective
  Representative Jim Cooper (D-TN)
  Rep. Cooper will address the growth in healthcare expenditures in the US and how this impacts government-supported medical care, along with the challenges of orchestrating an effective Congressional response to the problem.
9:00 a.m. Value-Based Healthcare in the U.S. – A Health System Perspective
  Thomas R. Graf, MD, Chief Medical Officer, Population Health and Longitudinal Health Care Services Lines, Geisinger Health System
  Dr. Graf will discuss how providers can successfully respond to population healthcare needs while simultaneously containing healthcare costs, with an emphasis on new delivery systems such as Accountable Care Organizations (ACOs).
9:20 a.m. Moderated Q & A Session
9:35 a.m Value of Echo in Specific Populations – Moderated by Michael H. Picard, MD, FACC, FASE, FAHA
  Panelists Include: Randolph P. Martin, MD, FACC, FASE, FESC; Jack Rychik, MD, FACC;  Steven A. Goldstein, MD
  This panel will discuss the role of echocardiography in the management of a variety of patients, including those with cancer, fetal heart abnormalities, and complex myocardial infarction.
10:05 a.m. Echo – The Patient Perspective – Moderated by Dr. Randolph P. Martin
  Panelists Include: Sarah Woodruff, Heart 2 Heart Ambassador for the Adult Congenital Heart Association (ACHA); William Wallace, Executive Director of US Ignite;Alexis Isenberg, Principal and Owner of The Lexis Group, LLC
The audience will hear from several patients with different backgrounds, about how echo has impacted their care, both as an initial diagnostic tool as well as lifelong monitoring.
10:35 a.m. Summary / Q & A
10:40 a.m.  Break (20 minutes)
11:00 a.m. Value of Echo in Clinical Cardiology – Moderated by Dr. Michael H. Picard
  Panelists Include: Theodore P. Abraham, MD, FACC, FASE; Linda D. Gillam, MD, MPH, FASE; Pamela S. Douglas, MD, MACC, FASE, FAHA
  This panel will focus on the role of echocardiography in Heart Failure, Valvular Heart Disease, Coronary Artery Disease, and Heart Disease in Women.
11:35 a.m. Summary / Q & A
11:40 a.m.  Value-Based Healthcare – The Payer Perspectives – Moderated by David H. Wiener, MD, FACC, FAHA, FASE
  Panelists Include: John C. Pilotte from CMS; Amol Navathe, MD, PhD, of Navigant Consulting, Inc.; and Anthony V. Coletta, MD, MBA, President and CEO of Tandigm Health; and Susan Nedza, MD, MBA, FACEP, Chief Medical Officer, AIM Specialty Health, Inc.(a subsidiary of WellPoint)
  The transition to value-based payment systems is led by government and regulatory agents, as well as private insurers. This panel will feature leaders from both payer realms, discussing the frameworks behind policies they are implementing to incentivize population health and value-based care.  The panel will also explore how cardiovascular imaging may be utilized in these new payment models.
12:40 – 1:40 p.m. LUNCH (includes the following session)
12:55 – 1:15 p.m. Echo’s Impact: A Global Vision
  Anthony J. Dean, MD, FAAEM, FACEP, Director, Division of Emergency Ultrasonography, University of Pennsylvania Medical Center
  From septic shock in North America to dehydration and tuberculosis in Africa, technological advances now allow echocardiography to be utilized in the management of time-critical illnesses in resource-poor healthcare settings in both developing and industrialized countries.  The potential benefit for patients with common life-threatening conditions comes with a commensurate challenge for medical education.  This session will discuss these issues, and efforts by the ASE and WINFOCUS to fill the knowledge and training gap.
1:40 p.m. Echo: The Value Choice in Cardiac Imaging – Moderated by James D. Thomas, MD, FASE, FACC
  Panelists include: Thomas J. Ryan, MD, FACC, FASE; R. Parker Ward, MD, FACC, FASE, FASNC
  This panel will discuss echo’s comparative value among the cardiac imaging modalities, including examples from the ACCF/AHA/ASE multi-modality AUC guidelines.
2:10 p.m. Summary / Q & A
2:15 p.m. Interactive Sessions
Attendees will be invited to participate in interactive discussion; more details will be provided at a later date.
  Group A, Patient-centered Care
Moderated by: Kenneth D. Horton, RCS, RDCS, FASE of Intermountain Heart Institute and Joseph Kreeger, RCCS, RDCS, FASE of Children’s Healthcare of Atlanta

Topics:  An Institute for Healthcare Improvement panel recently called on physicians not only to discuss treatment options with patients but also to promote greater cost transparency and information on the value of treatment options.  This group will discuss this type of request and also best ways to dialogue with patients about the value of CV Imaging, radiation safety, and the Choosing Wisely® campaign and its emphasis and impact on the relationship of the provider and patient.  

Group B, Improving Quality & Access of Echo
Moderated by: Partho P. Sengupta, MBBS, MD, DM, FASE of Mount Sinai Medical Center

Topics: There have many articles in the news related to the poor state of access to quality healthcare in the U.S.  This group will discuss best ways to create an environment that promotes adherence to quality metrics and access to excellent patient care specific to CV imaging. This could include accreditation, use of AUC guidelines, telemedicine, appropriate use of contrast to enhance suboptimal images, advantages and disadvantages of population screenings, and the recent study depicting the low use of imaging in general for heart failure patients.

Group C, New Technologies in Echo
Moderated by: Allan L. Klein, MD, FACC, FASE of Cleveland Clinic

Topics:  Technology and its impact on the world of medicine have been rapidly changing patient care.  This group will discuss the expansion of “smart” devices that help the provider to make correct measurements, the expansion of apps and wearables to assist practice, cutting-edge echo techniques such as Strain and 3D, and other new uses for CV ultrasound such as its aid as a therapeutic tool.

3:00 p.m. Breakout Discussion Recap
3:20 p.m. The Value of Echo in Research – Moderated by Patricia A. Pellikka, MD, FACC, FACP, FAHA, FASE
  Panelists include: Denis B. Buxton, PhD from the NHLBI; Pamela S. Douglas, MD, MACC, FASE, FAHA; Neil J. Weissman, MD, FACC, FASE
Research impacts patient care in a variety of ways, including clinical trials to assess new devices and pharmaceuticals, as an end-point measure in studies to determine efficacy of various treatment protocols, and through basic, applied, and translational research.  Panelists will consider echo’s role in these various research paradigms.
3:40 p.m.  Summary / Q&A from Audience
4:00 p.m. Presentation of the 2014 ASE Foundation Research Award  Dr. Tom Ryan, Chair of the ASEF Foundation
4:20 p.m. Wrap-up: Summit Chair Dr. Benjamin Byrd          
4:30 – 6:00 p.m. Hosted Reception